These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27668367)

  • 1. Big Data and Pharmacovigilance: The Role of Oncology Nurses.
    Glenn DG
    Clin J Oncol Nurs; 2016 Oct; 20(5):478-80. PubMed ID: 27668367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Trials: Nursing Roles During the Approval Process and Pharmacovigilance of Biosimilars.
    Sugay J
    Clin J Oncol Nurs; 2018 Oct; 22(5):27-32. PubMed ID: 30239528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
    Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing Roles: Clinical Implications Regarding Trends, Administration, and Education for Biosimilars in Oncology Practice.
    Zack E
    Clin J Oncol Nurs; 2018 Oct; 22(5):21-26. PubMed ID: 30239530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosimilars: Considerations for Oncology Nurses
.
    Vizgirda V; Jacobs I
    Clin J Oncol Nurs; 2017 Apr; 21(2):E54-E60. PubMed ID: 28315542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
    Bennett CL; Schooley B; Taylor MA; Witherspoon BJ; Godwin A; Vemula J; Ausdenmoore HC; Sartor O; Yang YT; Armitage JO; Hrushesky WJ; Restaino J; Thomsen HS; Yarnold PR; Young T; Knopf KB; Chen B
    PLoS One; 2019; 14(7):e0219521. PubMed ID: 31365527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy Administration: Oncology Nursing Society Recommendations
.
    Wiley K; LeFebvre KB; Wall L; Baldwin-Medsker A; Nguyen K; Marsh L; Baniewicz D
    Clin J Oncol Nurs; 2017 Apr; 21(2 Suppl):5-7. PubMed ID: 28315551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Cannabis: The Oncology Nurse's Role in Patient Education About the Effects of Marijuana on Cancer Palliation
.
    Clark CS
    Clin J Oncol Nurs; 2018 Feb; 22(1):E1-E6. PubMed ID: 29350699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing Application of Oral Chemotherapy Safety Standards:An Informal Survey.
    LeFebvre KB; Felice TL
    Clin J Oncol Nurs; 2016 Jun; 20(3):258-62. PubMed ID: 27206292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncology Nurses Can Use Evidence to Promote Oral Adherence.
    Sherner T
    ONS Connect; 2016 Jan; 31(1):20. PubMed ID: 26887103
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's MedWatch Program Monitors Drug Safety, But It Depends on Nurses to Report Adverse Events.
    Miller D
    ONS Connect; 2015 Sep; 30(3):49. PubMed ID: 26449124
    [No Abstract]   [Full Text] [Related]  

  • 12. The Nurse's Role in Prognosis-Related Communication in Pediatric Oncology Nursing Practice.
    Newman AR; Linder L; Haglund K
    J Pediatr Oncol Nurs; 2020; 37(5):313-320. PubMed ID: 31833447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Role of the Pediatric Nurse in Patient Education and Follow-up of Patients Receiving Oral Anticancer Treatment.
    Shinnick S
    J Pediatr Oncol Nurs; 2020; 37(1):46-54. PubMed ID: 31475636
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral agents for cancer: safety challenges and recommendations.
    Rudnitzki T; McMahon D
    Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):41-6. PubMed ID: 26030392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nurses' self-reported medication competence in relation to their pharmacovigilant activities in clinical practice.
    Johansson-Pajala RM; Martin L; Fastbom J; Jorsäter Blomgren K
    J Eval Clin Pract; 2015 Feb; 21(1):145-52. PubMed ID: 25327625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral chemotherapy medications: the need for a nurse's touch.
    Winkeljohn DL
    Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse drug reactions by nurses.
    Morrison-Griffiths S; Walley TJ; Park BK; Breckenridge AM; Pirmohamed M
    Lancet; 2003 Apr; 361(9366):1347-8. PubMed ID: 12711472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.
    Conforti A; Opri S; D'Incau P; Sottosanti L; Moretti U; Ferrazin F; Leone R
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):597-602. PubMed ID: 22337264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passing up paper: Electronic systems improve safety in chemotherapy ordering and management.
    Coghill AS
    ONS Connect; 2014 Mar; 29(1):16-20. PubMed ID: 24669527
    [No Abstract]   [Full Text] [Related]  

  • 20. Adherence to Oral Agents for Cancer. The Nurse's Role in an Evolving Phenomenon.
    Walker S
    ONS Connect; 2016 Jan; 31(1):14-8. PubMed ID: 26887101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.